Digital Pathology and AI-Assisted Diagnostics: What Changes in the Indian Laboratory

Digital pathology has been discussed as an imminent transformation for over a decade. What has actually changed in Indian laboratory practice is more incremental and more specific than the broader “AI will transform pathology” framing suggests. This article sets aside the hype and looks at what digital pathology and AI-assisted diagnostics concretely alter for a working pathologist — in reporting workflow, quality assurance, and turnaround time — and what remains unchanged.

This is a technology-and-practice piece, not a career guide. For pathology subspecialty and career pathway content, see our comparison of Fellowship in Molecular Pathology vs Cytopathology, and MGA’s Fellowship in Pathology for the foundational program.

Market growth figures for India’s digital pathology sector vary substantially across research providers depending on methodology and market definition; directional growth is consistently reported, though we avoid citing a single disputed figure here.

What digital pathology actually is — and is not

Digital pathology, at its core, is the digitisation of the glass slide. A whole slide imaging (WSI) scanner captures a high-resolution digital image of the entire slide, which the pathologist then views, annotates, and reports on a computer screen rather than through a microscope eyepiece. The digital image can be stored, transmitted, shared for consultation, and — where validated systems are in place — analysed by computational tools.

It is worth being precise about what this is not. Digital pathology is not, by itself, a diagnostic method — it is an image acquisition and viewing method. The diagnostic reasoning remains the pathologist’s, whether performed on glass or on screen. AI-assisted diagnostics is a separate, additional layer that can be built on top of digitised images — but digitisation and AI analysis are not the same thing, and a laboratory can digitise its workflow without deploying any AI tools at all.

In India, scanner devices currently represent the largest single segment of digital pathology market activity, reflecting where laboratories are actually investing — in the acquisition and viewing infrastructure — ahead of widespread AI deployment. Institutions such as KIMS Odisha have publicly commissioned whole slide scanning systems as part of routine cancer diagnosis workflows, illustrating the practical, incremental nature of adoption rather than a wholesale technology replacement.

What changes in reporting workflow

Screen-based sign-out replaces the microscope for primary review

The most direct workflow change is that primary diagnostic review shifts from eyepiece to screen. This changes ergonomics, requires monitor calibration standards to preserve colour and detail fidelity, and requires a different visual scanning discipline — moving across a digital slide is not identical to moving a physical slide under a microscope, and pathologists transitioning to digital sign-out typically undergo a validation period comparing their digital and glass-slide diagnostic concordance before full digital transition.

Digital annotation and case marking

Digital slides allow annotation tools — marking regions of interest, measuring dimensions directly on the image, and flagging areas for a colleague’s review — that are more precise and shareable than physical slide marking. This is a genuine workflow improvement for teaching, multidisciplinary case review, and documentation.

Remote consultation and second opinions

Perhaps the most immediately valuable change: a digitised slide can be shared instantly with a specialist anywhere, without physically shipping the glass slide. For a complex or unusual case requiring subspecialty input, this collapses what was previously a multi-day courier process into a same-day digital consultation. This capability underpins much of the telepathology discussion in the Indian context (covered below).

Integration with laboratory information systems

Digital pathology platforms increasingly integrate with laboratory information systems (LIS), linking the digital image directly to the patient record, prior reports, and relevant clinical data — reducing the manual cross-referencing that glass-slide workflows require.

Where AI-assisted diagnostics genuinely help today

The realistic, current-state role of AI in pathology is narrow and task-specific — not the general diagnostic replacement that popular framing sometimes suggests. The applications with genuine, demonstrated value fall into a few defined categories.

Quantification tasks

Counting mitotic figures, quantifying Ki-67 proliferation index, and measuring immunohistochemistry staining intensity are tasks that are time-consuming and subject to inter-observer variability when performed manually. AI-assisted quantification tools perform these specific counting and measurement tasks with good reproducibility, and are among the most mature and clinically adopted AI applications in pathology internationally.

Screening and triage in high-volume cytology

In cervical cytology screening, AI-assisted pre-screening can flag slides most likely to contain abnormal cells for prioritised pathologist review — a triage function that helps manage high case volumes rather than a diagnostic replacement. The pathologist still makes the final diagnostic call on flagged and unflagged material according to laboratory protocol.

Pattern detection as a second check

AI tools trained to flag specific patterns — certain tumour morphologies, particular infectious organisms, specific staining patterns — can serve as a second-check overlay, similar in concept to spell-check: a prompt for the pathologist to look again at a specific region, not a replacement diagnosis. This use case is gaining traction as a quality assurance layer rather than a primary diagnostic tool.

Workflow and turnaround acceleration

Industry analysis has reported that AI-assisted image analysis can meaningfully reduce the time required for certain whole-slide review tasks compared to fully manual analysis — a workflow efficiency gain rather than a diagnostic accuracy claim in itself. The efficiency benefit is most apparent in high-volume, repetitive quantification tasks rather than complex diagnostic interpretation.

Where AI does not replace pathologist judgment

It is equally important to be clear about the current limitations, because overstating AI capability creates both clinical risk and unrealistic expectations among practising and training pathologists.

Complex diagnostic synthesis: Final diagnosis in pathology frequently requires integrating morphological findings with clinical history, prior results, and ancillary test data in a way that current AI tools are not positioned to perform independently. AI tools support specific sub-tasks within the diagnostic process; the synthesis and final sign-out responsibility remains with the pathologist.

Novel and atypical presentations: AI models are trained on the patterns present in their training data. Atypical presentations, rare entities, and novel patterns — precisely the cases where pathologist expertise matters most — are where AI tools are least reliable and where over-dependence carries the greatest diagnostic risk.

Regulatory and validation status: Clinical deployment of AI diagnostic tools requires validation appropriate to the jurisdiction and the specific clinical claim being made. A tool validated for research use is not equivalent to one validated and approved for primary diagnostic use. Laboratories should not treat research-grade AI outputs as clinically actionable without appropriate validation.

Medico-legal accountability: The pathologist who signs out the report retains professional and legal accountability for the diagnosis, regardless of what AI-assisted tools contributed to the process. This accountability structure is unlikely to change even as AI tool sophistication increases.

Telepathology and remote reporting in the Indian context

Telepathology — the practice of transmitting pathology images for remote diagnosis or consultation — has particular relevance in India given the geographic concentration of subspecialty pathology expertise in major cities and the shortage of trained pathologists relative to case volume across the wider healthcare system.

The practical telepathology use cases in Indian practice include: rural or district hospital laboratories sending digitised slides to a subspecialist for definitive diagnosis or second opinion; intraoperative frozen section consultation where a remote specialist reviews a digitised frozen section image in real time to guide surgical decision-making; and structured second-opinion networks connecting smaller diagnostic labs with tertiary reference centres for complex cases.

The infrastructure requirement for reliable telepathology extends beyond the scanner itself — adequate bandwidth for transmitting large digital images, validated remote-viewing software, and clear protocols for who holds final diagnostic responsibility when a remote consultation is involved. Infrastructure gaps and cost of implementation remain cited barriers to wider telepathology adoption in less-resourced settings, particularly rural areas, even as urban and tertiary centre adoption grows.

Quality assurance and validation implications

Moving to digital primary diagnosis is not a simple hardware swap — it carries specific quality assurance obligations that laboratories need to plan for deliberately.

Validation before clinical deployment

Before a laboratory relies on digital review for primary diagnosis, pathologists typically need to demonstrate diagnostic concordance between digital and glass-slide review across a validation case set. This is a deliberate, structured process — not an assumption that digital and glass are automatically equivalent for every case type and stain.

Image quality standards

Scanner resolution, colour calibration, focus quality across the full slide, and monitor display standards all affect diagnostic image fidelity. A laboratory introducing digital pathology needs documented standards for these parameters, along with a process for identifying and re-scanning inadequate images rather than proceeding with suboptimal digital slides.

AI tool-specific validation

Where AI-assisted tools are introduced, they require their own validation specific to the laboratory’s patient population, staining protocols, and scanner characteristics — a tool validated elsewhere is not automatically valid for a different laboratory’s specific technical setup without local verification.

Data governance and interoperability

Digital Imaging and Communications in Medicine (DICOM) standards have been increasingly adopted to enable interoperability between different scanners, storage systems, and viewing platforms — reducing vendor lock-in and enabling images to move between systems reliably, which matters for both routine practice and the growing telepathology and consultation networks described above.

Turnaround time: what actually speeds up, what doesn’t

Turnaround time claims around digital pathology deserve a grounded look rather than a blanket assumption of improvement.

What speeds up: Remote consultation turnaround improves substantially — a digital image can reach a subspecialist in minutes rather than the days a physical slide courier requires. AI-assisted quantification tasks that were previously manually counted can be completed faster once the tool is validated and integrated into the workflow. Multi-site laboratory networks can distribute case review load more flexibly when slides are digital rather than physically located at a single site.

What doesn’t automatically speed up: The scanning process itself adds a step to the workflow — physical slide preparation still must happen before digitisation, and scanning time depends on slide count and scanner throughput. During the transition period, laboratories running parallel digital and glass workflows for validation purposes may see turnaround unchanged or temporarily slower rather than faster. Complex diagnostic reasoning time is not meaningfully reduced by digitisation alone — the pathologist still needs the same cognitive time to reach a difficult diagnosis, whether viewing glass or screen.

What this means for pathologist skill requirements

The practical implication for practising and training pathologists is not that morphological diagnostic skill becomes less important — it remains the foundation of the specialty. What changes is the addition of digital literacy as a working requirement: comfort with digital slide navigation, understanding of image quality parameters that affect diagnostic reliability, familiarity with the validation requirements around AI-assisted tools, and judgment about when an AI-flagged finding warrants closer scrutiny versus routine confirmation.

Pathologists building subspecialty depth in areas like molecular pathology find that digital and computational literacy compounds naturally with molecular diagnostics training, since both involve structured, technology-mediated diagnostic workflows. Doctors evaluating their pathology subspecialty direction can review our comparison of Fellowship in Molecular Pathology vs Cytopathology for a broader view of where the specialty is heading across different diagnostic disciplines.

Related articles and programs

Frequently asked questions

What is digital pathology?

Digital pathology is the use of whole slide imaging scanners to convert glass microscope slides into high-resolution digital images that pathologists view, annotate, and report on a screen rather than through a microscope. It enables remote consultation, digital case sharing, and serves as the foundation on which AI-assisted analysis tools can be built, though digitisation and AI analysis are separate capabilities.

Is AI replacing pathologists in India?

No. Current AI-assisted diagnostic tools perform specific, narrow tasks — quantification (such as Ki-67 or mitotic counting), screening triage in high-volume cytology, and pattern-flagging as a second check — rather than independently generating final diagnoses. The pathologist retains diagnostic and medico-legal responsibility for the signed-out report. AI adoption in Indian pathology is still emerging, constrained by infrastructure and validation requirements, particularly outside major urban centres.

What is telepathology and how is it used in India?

Telepathology is the transmission of pathology images for remote diagnosis or consultation. In the Indian context, it is used to connect rural or district hospital laboratories with subspecialist pathologists in tertiary centres for definitive diagnosis, second opinions, and intraoperative frozen section consultation. Bandwidth, validated viewing infrastructure, and clear protocols for diagnostic accountability are practical requirements for reliable telepathology practice.

Does digital pathology make diagnosis faster?

It depends on the specific workflow. Remote consultation and second-opinion turnaround improve substantially, since digital images can be shared instantly rather than requiring physical slide transport. However, the scanning step itself adds workflow time, and complex diagnostic reasoning is not inherently faster on screen versus glass. During the initial validation period when laboratories run parallel digital and glass workflows, turnaround may be temporarily unchanged or slower rather than faster.

Do pathologists need special training for digital pathology and AI tools?

Digital slide navigation, understanding of image quality parameters affecting diagnostic reliability, and judgment about validated AI tool outputs are increasingly relevant skills, though morphological diagnostic expertise remains the core of pathology practice. Laboratories transitioning to digital workflows typically require pathologists to complete a validation period demonstrating diagnostic concordance between digital and glass-slide review before relying on digital sign-out for primary diagnosis.